Determinants of hepcidin levels in sepsis-associated acute kidney injury: Impact on pAKT/PTEN pathways?

Journal of Immunotoxicology

Volumn 13, Issue 5, 2016, Pages 751-757

  Schaalan, Mona F ^a   Mohamed, Walid A ^b  

^a Egypt   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Acute kidney injury; Erythropoietin; Hepcidin; Hypoxia inducing factor 1 ; Pakt; Phosphatase and tensin homolog; Sepsis

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CREATININE; ERYTHROPOIETIN; HEPCIDIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; URIC ACID; EPO PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; IRON; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; KIDNEY DISEASE; LEUKOCYTE; MALE; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPSIS; SEPSIS ASSOCIATED ACUTE KIDNEY INJURY; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY FAILURE; CELL CULTURE; COHORT ANALYSIS; GENETICS; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ACUTE KIDNEY INJURY; CELLS, CULTURED; COHORT STUDIES; ERYTHROPOIETIN; HEPCIDINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IRON; ONCOGENE PROTEIN V-AKT; PTEN PHOSPHOHYDROLASE; SEPSIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84973596279     PISSN: 1547691X     EISSN: 15476901     Source Type: Journal    
DOI: 10.1080/1547691X.2016.1183733     Document Type: Article

References (34)

1. Bone RC, Balk RA, Cerra FB, Dellinger EP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1656-1662.
2. Carracedo A, Pandolfi P. 2008. The PTEN-PI3K pathway: Of feedbacks and cross-talks. Oncogene 27: 5527-5541.
3. den Elzen WP, de Craen AJ, Wiegerinck ET, Westendorp RG, Swinkels DW, Gussekloo J. 2013. Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study. Haematologica 98: 448-454.
4. Engelman JA, Luo J, Cantley LC. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 7: 606-619.
5. Ganz T. 2011. Hepcidin and iron regulation, 10 years later. Blood. 117: 4425-4433.
6. Glassford N, Schneider A, Eastwood G, Peck L, Young H, Westerman M, Ostland V, Bellomo R. 2011. Renal biomarkers are less useful at predicting acute kidney injury in patients with sepsis than those without. Crit Care. 15:S5.
7. Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, Kellum JA. 2014. A unified theory of sepsis-induced acute kidney injury: Inflammation, microcirculatory dysfunction, bioenergetics, and tubular cell adaptation to injury. Shock 41: 3-11.
8. Haase M, Bellomo R, Haase-Fielitz A. 2010. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol. 55: 2024-2033.
9. Heyman SN, Rosen S, Rosenberger C. 2011. A role for oxidative stress. Contrib Nephrol. 174: 138-148.
10. Hill P, Shukla D, Tran MG, Aragones J, Cook HT, Carmeliet P, Maxwell PH. 2008. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol. 19: 39-46.
11. Hotchkiss RS, Karl IE. 2003. The pathophysiology and treatment of sepsis. N Engl J Med. 348: 138-150.
12. Huet O, Cherrau C, Nicco C, Dupic L, Conti M, Borderle D, Pene F, Vicaut E, Benhamou E, Mira JP, et al. 2008. Pivotal role of glutathione depletion in plasma-induced endothelial oxidative stress during sepsis. Crit Care Med. 36: 2328-2334.
13. International Society of Nephrology. 2012. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. 2: 1-138.
14. Katavetin P, Miyata T, Inagi R, Tanaka T, Sassa R, Ingelfinger JR, Fujita T, Nangaku M. 2006. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element. J Am Soc Nephrol. 17: 1405-1413.
15. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann W, Schulz-Knappe P, Adermann K. 2000. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits anti-microbial activity. FEBS Lett. 480: 147-150.
16. Lan R, Geng H, Polichnowski AJ, Singha PK, Saikumar P, McEwen DG, Griffin KA, Koesters R, Weinberg JM, Bidani AK, et al. 2012. PTEN loss defines a TGFb-induced tubule phenotype of failed differentiation and jnk signaling during renal fibrosis. Am J Physiol. 302:F1210-F1223.
17. Li XJ, Zhang GX, Sun N, Sun Y, Yang LZ, Du YJ. 2013. Protective effects of erythropoietin on endotoxin-related organ injury in rats. J Huazhong Univ Sci Technolog Med Sci. 33: 680-686.
18. Liu Q, Davidoff O, Niss K, Haase VH. 2012. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest. 122: 4635-4644.
19. Matsuda S, Kobayashi M, Kitagishi Y. 2013. Roles for PI3K/AKT/PTEN pathway in cell signaling of non-alcoholic fatty liver disease. ISRN Endocrinol. 2013:Article ID 472432.
20. Moore EM, Bellomo R, Nichol AD. 2012. The meaning of acute kidney injury and its relevance to intensive care and anaesthesia. Anaesth Intensive Care. 40: 929-948.
21. Morrell E, Kellum J, Pastor-Soler N, Hallows, K. 2014. Septic acute kidney injury: Molecular mechanisms and the importance of stratification and targeting therapy. Crit Care. 18: 1-10.
22. Nangaku M, Inagi R, Miyata T, Fujita T. 2008. Hypoxia and hypoxia-inducible factor. Nephron Exp Nephrol. 110: 1-7.
23. Nemeth E, Ganz T. 2006. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 28: 323-342.
24. Peters HP, Laarakkers C, Pickkers P, Masereeuw R, Boerman OC, Eek A, Cornelissen EA, Swinkels DW, Wetzels JF. 2013. Tubular reabsorption and local production of urine hepcidin-25. BMC Nephrol. 14: 1.
25. Prowle JR, Ostland V, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Bagshaw SM, Haase-Fielitz A, Haase M, Westerman M, et al. 2011. Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass. Nephrol Dial Transplant. 27: 595-602.
26. Rosenberger C, Rosen S, Shina A, Bernhardt W, Wiesener MS, Frei U, Eckardt KU, Heyman SN. 2006. Hypoxia-inducible factors and tubular cell survival in isolated perfused kidneys. Kidney Int. 70: 60-70.
27. Sawyer DB, Loscalzo J. 2002. Myocardial hibernation: Restorative or pre-terminal sleep? Circulation 105: 1517-1519.
28. Tran M, Tam D, Bardia A, Bhasin M, Rowe GC, Kher A, Zsengeller ZK, Akhavan-Sharif MR, Khankin EV, Saintgeniez M, et al. 2011. PGC-1a promotes recovery after acute kidney injury during systemic inflammation in mice. J Clin Invest. 121: 4003-4014.
29. van Eijk LT, Kroot JJ, Tromp M, van der Hoeven JG, Swinkels DW, Pickkers P. 2011. Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: An observational study. Crit Care. 15:R9.
30. Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. 2008. Pathophysiology of septic acute kidney injury: What do we really know? Crit Care Med. 36: 198-203.
31. Wu TW, Tabangin M, Kusano R, Ma Y, Ridsdale R, Akinbi H. 2012. The utility of serum hepcidin as a biomarker for late-onset neonatal sepsis. J Pediatr. 162: 67-71.
32. Zeng C, Chen Q, Zhang K, Chen Q, Song S, Fang X. 2015. Hepatic hepcidin protects against polymicrobial sepsis in mice by regulating host iron status. Anesthesiology 122: 374-386.
33. Zhang X, Jin M, Wu H, Nadasdy T, Nadasdy G, Harris N, Greenchurch K, Nagaraja H, Yu C, Hebert L, et al. 2008. Biomarker discovery for lupus nephritis through longitudinal urine proteomics. Kidney Int. 74: 799-807.
34. Zhang Z. 2015. Biomarkers, diagnosis and management of sepsis-induced acute kidney injury: A narrative review. Heart Lung Vessel. 7: 64-73.